Copyright
©2009 Baishideng Publishing Group Co.
World J Radiol. Dec 31, 2009; 1(1): 3-14
Published online Dec 31, 2009. doi: 10.4329/wjr.v1.i1.3
Published online Dec 31, 2009. doi: 10.4329/wjr.v1.i1.3
Evaluation of the (primary) tumor (‘T’) |
Clinical |
TX: can not evaluate primary tumor |
T0: no evidence of primary tumor |
T1: clinically inapparent tumor neither palpable nor visible by imaging |
T1a: tumor was incidentally found in less than 5% of prostate tissue resected |
T1b: tumor was incidentally found in more than 5% of prostate tissue resected |
T1c: tumor was found in a needle biopsy performed because of elevated serum PSA |
T2: tumor confined within prostate1 |
T2a: the tumor is in half or less than half of one of the prostate gland's 2 lobes |
T2b: the tumor is in more than half of one lobe, but not both |
T2c: the tumor is in both lobes |
T3: the tumor has spread through the prostatic capsule (if it is only part-way through, it is still T2) |
T3a: the tumor has spread through the capsule on one or both sides |
T3b: the tumor has invaded one or both seminal vesicles |
T4: the tumor has invaded adjacent structures other than seminal vesicles (e.g. external sphincter, rectum, bladder, levator muscles, and/or pelvic wall) |
Pathologic (pT)2 |
pT2: organ confined |
pT2a: unilateral, one-half of one side or less |
pT2b: unilateral, involving more than one-half of side but not both sides |
pT2c: bilateral disease |
pT3: extraprostatic extension |
pT3a: extraprostatic extension or microscopic invasion of bladder neck |
pT3b: seminal vesicles invasion |
pT4: Invasion of rectum, levator muscles, and/or pelvic wall |
Evaluation of the regional lymph nodes (‘N’) |
(p)NX: regional lymph nodes were not assessed (sampled) |
(p)N0: there has been no spread to the regional lymph nodes |
(p)N1: there has been spread to the regional lymph nodes |
Evaluation of distant metastasis (‘M’) |
M0: there is no distant metastasis |
M1: there is distant metastasis |
M1a: the cancer has spread to lymph nodes beyond the regional ones |
M1b: the cancer has spread to bone |
M1c: the cancer has spread to other sites (regardless of bone involvement) |
- Citation: Wang L. Incremental value of magnetic resonance imaging in the advanced management of prostate cancer. World J Radiol 2009; 1(1): 3-14
- URL: https://www.wjgnet.com/1949-8470/full/v1/i1/3.htm
- DOI: https://dx.doi.org/10.4329/wjr.v1.i1.3